Upcoming Events
November 6, 2026 | 10:15 AM CST
Presentation: HRS/BHB-1893, a Next-Generation Cardiac Myosin Inhibitor, Improves Indices of Diastolic Function in Non-Obstructive Hypertrophic Cardiomyopathy: Evidence From in vitro Studies and Patients
Location
Chicago, IL
November 6, 2026 | 2:15 PM CST
Presentation: Long-Term Efficacy and Safety of BHB/HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy: Results From the 52-Week Extension Period
Location
Chicago, IL
November 6, 2026 | 4:35 PM EST
Past Events
September 30, 2026 | 12:30 PM EDT
May 11, 2026
Presentation: Phase 2 randomized, double-blind, placebo-controlled study to evaluate BHB/HRS-1893 in adults with symptomatic non-obstructive hypertrophic cardiomyopathy
Location
Barcelona, Spain
April 1, 2026
Virtual Fireside Chat
March 28, 2026
Presentation: Efficacy and Safety of BHB/HRS-1893 In Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From a 12-Week Phase 2 Study
Location
New Orleans, LA